Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. > Summary
Court Case Number 2023-1169
Filing Date Nov 21, 2022
Termination Date Jun 25, 2024
Appeal From DCT
NOS 830
Status Terminated
Court U.S. Court Of Appeals, Federal Circuit
Appellant Attorneys
10Amarin Corporation
Attorney Name: Robert M. Oakes
Fish & Richardson
Amarin Corporation
Attorney Name: Nathan K. Kelley
Perkins Coie
Amarin Corporation
Attorney Name: Nathanael D. Andrews
Perkins Coie
Amarin Pharmaceuticals Ireland Limited
Attorney Name: Nathan K. Kelley
Perkins Coie
Amarin Pharmaceuticals Ireland Limited
Attorney Name: Nathanael D. Andrews
Perkins Coie
Mochida Pharmaceutical Co., Ltd.
Attorney Name: Nathan K. Kelley
Perkins Coie
Mochida Pharmaceutical Co., Ltd.
Attorney Name: Nathanael D. Andrews
Perkins Coie
Amarin Pharmaceuticals Ireland Limited
Attorney Name: Mark T. Smith
Perkins Coie
Amarin Corporation
Attorney Name: Mark T. Smith
Perkins Coie
Amarin Corporation
Attorney Name: Nathanael D. Andrews
Perkins Coie
Appellee Attorneys
6Health Net, Inc.
Attorney Name: John C. Phillips Jr.
Phillips, McLaughlin & Hall, P.A.
Hikma Pharmaceuticals PLC
Attorney Name: Charles B. Klein
Winston & Strawn
Hikma Pharmaceuticals PLC
Attorney Name: Claire A. Fundakowski
Winston & Strawn
Hikma Pharmaceuticals PLC
Attorney Name: Alison M. King
Winston & Strawn
Hikma Pharmaceuticals PLC
Attorney Name: Eimeric Reig-Plessis
Winston & Strawn
